الصفحة الرئيسية>>Signaling Pathways>> Membrane Transporter/Ion Channel>> Potassium Channel>>SKA-111

SKA-111

رقم الكتالوجGC70205

SKA-111 هو منشط انتقائي من فانيل البوتاسيوم KCa 3.1، يثير فرط استقطاب غشاء KCa 3.1 في الخلية البطانية للخنازير.

Products are for research use only. Not for human use. We do not sell to patients.

SKA-111 التركيب الكيميائي

Cas No.: 1369170-24-0

الحجم السعر المخزون الكميّة
5 mg
171٫00
متوفر
10 mg
288٫00
متوفر
25 mg
576٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents
SKA-111 is a selective activator of potassium phannel KCa 3.1 , evokes KCa 3.1 membrane hyperpolarization in porcine endothelial cell. SKA-111 is capable of improving Bradykinin -induced coronary dilations in the isolated rat heart and can be used for cardiovascular disease research.

SKA-111 (1 μM, 5 min) evokes KCa 3.1 membrane hyperpolarization in porcine endothelial cell[1].
SKA-111 (1 μM, 5 min) induces significantly augmented the Bradykinin-induced endothelium-derived hyperpolarization (EDH)-type relaxation in large porcine coronary arteries (PCA) [1].

SKA-111 (1 μM for cardiac perfusion) improves Bradykinin -induced coronary dilations in the isolated rat heart[1].

References:
[1]. Oliván-Viguera A, et.al. Vascular Reactivity Profile of Novel KCa 3.1-Selective Positive-Gating Modulators in the Coronary Vascular Bed. Basic Clin Pharmacol Toxicol. 2016 Aug;119(2):184-92.

مراجعات

Review for SKA-111

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for SKA-111

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.